Search filters

List of works by Mitchell Gross

3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion

scientific article published on 21 January 2012

A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors

scientific article published on 15 December 2012

A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer

scientific article

A Self-Focusing Acoustic Transducer That Exploits Cytoskeletal Differences for Selective Cytolysis of Cancer Cells

A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel

scientific article published on 8 February 2015

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

scientific article

A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.

scientific article

A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients

scientific article

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.

scientific article published in August 2007

Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.

scientific article published in April 2017

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.

scientific article published on 21 August 2012

Applications of Proteomics in Prostate Cancer

Automated analysis of co-localized protein expression in histologic sections of prostate cancer

scientific article

Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling

scientific article published on August 2010

Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer

scientific article

Blood-based gene expression profiling in castrate-resistant prostate cancer.

scientific article published on 14 September 2015

Body image predicts quality of life in men with prostate cancer

scientific article

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

scientific article published on 25 March 2010

Combinatory localized cytolysis with micron precision by acoustic transducer array for fast screening of drug induced cytoskeleton alteration

Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line

scientific article published on 3 February 2012

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer

scientific article

Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells

scientific article (publication date: 28 June 2001)

Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells

scientific article published on 28 January 2019

Erratum to: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

scholarly article published in Investigational New Drugs

Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression

scientific article

Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.

scientific article published on April 2009

Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.

scientific article

Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors.

scientific article published on 2 June 2014

Label-free detection of prostate-specific antigen with FBAR-based sensor with oriented antibody immobilization

Micro-localized cell lysis by low power Focused Acoustic Transducer

Multimodality imaging in biochemical recurrence of prostate cancer: Utility of 18F-NaF PET/CT in early detection of metastasis

scientific article published on May 14, 2012

Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer

scientific article

PIASy-mediated repression of the androgen receptor is independent of sumoylation

scientific article

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer

scientific article published on 03 March 2020

Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen-Independent Prostate Cancer: Scientific Rationale and Study Design

article

Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping

scientific article published in May 2009

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer

scientific article

Prostate cancer: Age is nothing but a number

scientific article published on 12 November 2013

Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer?

scientific article

Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.

scientific article published in April 2006

Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells

scientific article

Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene.

scientific article published on 9 June 2006

Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC).

scientific article

Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study.

scientific article published on 15 October 2011

Safety and preliminary efficacy analysis of the mTOR inhibitor ridaforolimus in patients with taxane-treated, castration-resistant prostate cancer

scientific article published on 12 June 2012

Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design

scientific article published on 28 July 2015

Self focusing acoustic transducer (SFAT) with 10-mm focal length for cancer-specific localized cytolysis of 3D cell spheroids in 3D Matrigel

Show us a sign: the search for "game changing" prostate cancer biomarkers.

scientific article

The epothilones: new therapeutic agents for castration-resistant prostate cancer.

scientific article published on 30 September 2011

Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies

scientific article published on 6 February 2015